https://orcid.org/0000-0002-6879-5415
Figures
Abstract
Purpose
To present a classification of inherited retinal diseases (IRDs) and evaluate its content coverage in comparison with common standard terminology systems.
Methods
In this comparative cross-sectional study, a panel of subject matter experts annotated a list of IRDs based on a comprehensive review of the literature. Then, they leveraged clinical terminologies from various reference sets including Unified Medical Language System (UMLS), Online Mendelian Inheritance in Man (OMIM), International Classification of Diseases (ICD-11), Systematized Nomenclature of Medicine (SNOMED-CT) and Orphanet Rare Disease Ontology (ORDO).
Results
Initially, we generated a hierarchical classification of 62 IRD diagnosis concepts in six categories. Subsequently, the classification was extended to 164 IRD diagnoses after adding concepts from various standard terminologies. Finally, 158 concepts were selected to be classified into six categories and genetic subtypes of 412 cases were added to the related concepts. UMLS has the greatest content coverage of 90.51% followed respectively by SNOMED-CT (83.54%), ORDO (81.01%), OMIM (60.76%), and ICD-11 (60.13%). There were 53 IRD concepts (33.54%) that were covered by all five investigated systems. However, 2.53% of the IRD concepts in our classification were not covered by any of the standard terminologies.
Conclusions
This comprehensive classification system was established to organize IRD diseases based on phenotypic and genotypic specifications. It could potentially be used for IRD clinical documentation purposes and could also be considered a preliminary step forward to developing a more robust standard ontology for IRDs or updating available standard terminologies. In comparison, the greatest content coverage of our proposed classification was related to the UMLS Metathesaurus.
Citation: Sabbaghi H, Madani S, Ahmadieh H, Daftarian N, Suri F, Khorrami F, et al. (2023) A health terminological system for inherited retinal diseases: Content coverage evaluation and a proposed classification. PLoS ONE 18(8): e0281858. https://doi.org/10.1371/journal.pone.0281858
Editor: Alfred S. Lewin, University of Florida, UNITED STATES
Received: April 26, 2022; Accepted: February 2, 2023; Published: August 4, 2023
Copyright: © 2023 Sabbaghi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Additional data has been uploaded to the journal website as Supporting Information files.
Funding: The authors received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Inherited retinal diseases (IRDs) consist of various types of hereditary retinal dystrophies that are primarily involving the outer retina and retinal pigment epithelium (RPE) [1, 2]. Considering the progressive nature of IRDs which can lead to decreased vision-related quality of life (VRQoL), accurate diagnosis and identification of the causative gene mutations are important for genetic consulting as well as allocating research-based trials for the evolving therapies such as gene therapy [3–5]. Therefore, domain-specific ontologies and reference terminology systems are considered important tools that can facilitate documentation and representation of the complex IRD concepts based on their genotype-phenotype distinctions [6–8].
Clinical classifications and terminology systems are widely used for standardizing patients’ health information at the point of care for different purposes such as clinical, research, reimbursement, and epidemiological purposes [9–11]. Additionally, terminological systems are essential for structured documentation of patient data in Electronic Health Record (EHR) systems [12]. One of the crucial advantages of these systems is the establishment of a common controlled vocabulary for effective communication by capturing unified medical terms and concepts [13]. Furthermore, such structured contents can be reused for a variety of purposes and represented in many different information systems [10–15].
Based on the intended application, different terminological systems are available in the domain of medicine including Unified Medical Language System (UMLS), Online Mendelian Inheritance in Man (OMIM), International Classification of Diseases (e.g., ICD-11), Systematized Nomenclature of Medicine—Clinical Terms (SNOMED-CT) and Orphanet Rare Disease Ontology (ORDO) [16]. Each system has been developed for a particular purpose. For instance, UMLS is widely used for providing a unique code and term linkage between different terminological systems and facilitating mapping schemas that can be used to create and maintain local terminologies [17]. While ICD classifications can be employed for the identification of health trends, mortality and morbidity statistics [18] as well as clinical and health research purposes; OMIM is optimized for the classification of human genes and genetic disorders [19]. Recently, SNOMED-CT has been designated as the terminology of choice for the standardization of complex medical concepts, such as IRDs, at the point of care [20]. Additionally, Orphanet also represents a dedicated coding system for rare diseases by a stable and unique ORPHA number [8]. Since the above terminologies cover the IRDs domain, we have incorporated them all throughout our study.
An ontology consists of concepts that organize domain knowledge with defined terms, concepts, and their relationships in a given field of study. Ontologies are useful both for providing consistent domain concepts and representing structured data formats in order to facilitate the knowledge discovery process [21]. With regards to the importance of terminological systems in the recorded history of biological and natural sciences [22], Sergouniotis et al. [8] presented a hierarchical ontology for ocular phenotypes and rare ocular diseases that covered all the rare diseases not only IRD concepts. In addition, only the entities were extracted based on the two systems of Human Phenotype Ontology and Orphanet Rare Disease Ontology and did not include the genetic concepts. While in the present study, we desired to develop a dedicated classification, specifically for IRD concepts.
One of the preliminary steps in selecting or developing a new classification or ontology system is to search for existing ones. Evaluation of the content coverage of existing (or new) ontologies is a quintessential feature of each terminological (ontological) system. Content coverage presents the extent of content representation (either term or concept) for a developed terminology, based on the standards and is highly recommended to be evaluated in order to expand the adequacy of the content representation [10, 23]. A systematic review shows that there are few studies focusing on the content coverage evaluation of terminological systems in the ophthalmology domain [10]. In the study by Hwang et al. [12], content coverage analysis was conducted on five controlled terminological systems of ICD-9, Logical Observation Identifiers, Names, and Codes (LOINC), SNOMED-CT, Medical Entities Dictionary (MED), and Current Procedural Terminology, fourth edition (CPT-4). It was concluded that the content coverage of these five evaluated systems was not perfect for general ophthalmic concepts. In another study by Chiang et al. [13], higher content coverage was found for the SNOMED-CT system for general ophthalmic concepts in comparison with ICD-9, CPT-4 and MED terminological systems.
Lack of consistent coding of IRD concepts by terminological systems may result in documenting and extracting unreliable information from electronic systems including patient registries and electronic health records (EHRs). These issues may raise the challenges of semantic interoperability among electronic systems [24]. The objective of this study was two-sided: Firstly, we developed a classification for IRD concepts, and secondly, we evaluated the content coverage of some well-known terminological systems for our proposed IRD classification to validate this classification for documentation of IRD concepts.
Results
Our proposed classification for IRD concepts
Initially, during our literature review, we created a prototype classification that contained 62 IRD-related concepts based on anatomical and functional features as well as genetic characteristics in six categories (S1 Table). Gradually, such classification was expanded to 164 IRD concepts under the six main categories, represented by standard terminologies. During expert consultation sessions, several panel group discussions, and further literature review, the consensus agreed to retract eleven concepts from the proposed classification because they were not fully representing an IRD (S2 Table). Therefore, a final list was developed that contained 158 IRD concepts in six categories based on the phenotype identifications and their corresponding genetic subtypes (n = 412). In our proposed classification, the disease categorization was organized considering both anatomical and functional IRD entities in the following six categories: 1. Diffuse photoreceptor dystrophies (n = 15), 2. Macular dystrophies (n = 22), 3. Chorioretinal dystrophies (n = 12), 4. Inner retinal and/or vitreoretinal dystrophies (n = 4), 5. Retinal dystrophies associated with systemic disease (syndromic diseases) (n = 92), and 6. Congenital & stationary retinal diseases (n = 13). For further clarification of the twenty- one IRD concepts, we classified them under our proposed categories, which are performed based on the updated anatomic, functional and genetic information, although might be different from the previous classification of the standard terminological systems (S3 Table). Our final IRD classification is registered on the BioPortal website and can be accessed via this web address https://bioportal.bioontology.org/ontologies/IRD3.
Content coverage (term and concept) analysis
We evaluated our IRD classification against 5 terminological systems that we included in our scope. In general, UMLS had the greatest coverage of 90.51% compared with other evaluated systems including SNOMED-CT (83.54%), ORDO (81.01%), OMIM (60.76%), and ICD-11 (60.13%). Overall, there were 53 IRD concepts (33.54%) that were covered by all five investigated systems. However, 2.53% of the IRD concepts in our classification were not covered by any of the standard terminologies (S4 Table; for genetic classification, see Supplementary Excel sheet labeled as Terminological System for IRDs). Table 1 summarizes the coverage analysis of the developed IRD classification based on SNOMED-CT. Our classification was completely covered based on both terminologies and concepts within SNOMED-CT regarding diseases for chorioretinal dystrophies, and inner retinal and/ or vitreoretinal dystrophies. Even though there was no match for 16.46% (n = 26) of IRD concepts in SNOMED-CT, we were able to create an equivalent for 6.96% (n = 11) of the concepts by leveraging the post-coordination function in SNOMED-CT.
Table 2 shows content coverage for the remaining 4 terminologies (ICD-11, ORDO, OMIM, and UMLS), of our suggested IRD classification. UMLS and SNOMED-CT had the highest content coverage for all IRD categories, while the least content coverage was reported for ICD-11.
Discussion
This study proposes a classification for IRD concepts and terminologies. This will benefit sub-specialists in the field of IRD diseases, who are trying to go to a nomenclature system that facilitates the allocation of disorders into precise categories based on individual gene mutations, which is the result of improving diagnostic techniques. Evaluation of content coverage was based on the UMLS, ICD- 11, ORDO, OMIM and SNOMED- CT terminologies. The highest content coverage was obtained for the UMLS system due to the generalizability of this system for a variety of biomedical vocabularies [17].
One of the shortcomings of OMIM is that its concept coding is not based on a uniform pattern, hence, various IRD concepts with the same underlying gene were considered as a distinct diagnosis, while in some other cases one concept was defined as the main one and the other one was considered as an alternative term. For instance, RP14 "OMIM: # 600132" and LCA15 "OMIM: # 613843" were considered as two distinct phenotypes, although TULP1 is a single causative gene of both diagnoses. Conversely, LCA13 "OMIM: # 612712" is considered as the main term and RP53 "OMIM: # 612712" is defined as its alternative term when RDH12 is the causative gene for both phenotypes. To resolve this discrepancy, we considered a unique code for each causative gene, despite having various phenotypes, in our proposed classification. In addition, we adopted this approach in cases when a single gene was the causing factor of various IRD diagnoses. Another limitation of the OMIM terminology system is that all subtypes of each IRD concept were determined only by a single OMIM code like "Retinitis punctata albescens; # 136880", whereas, in our proposed classification, each subtype has a unique code.
Acceptable content coverage was observed in ICD-11 for non-genetic based IRD concepts; however, its accuracy needs to be further evaluated. For instance, the same code of 5C56.00 is assigned to different types of GM Ganliosidosis.
Although a high level of content coverage was obtained for UMLS Metathesaurus, it is not widely incorporated in electronic health record and data entry systems. Therefore, enhancing content coverage of the more commonly used clinical terminologies such as ICD and SNOMED-CT could facilitate a wider adoption.
There were eleven IRD diagnoses that are represented ORDO classification system; however, we decided to exclude them from our proposed classification. IRD concepts that were removed from our classification, together with a brief description of the reason, are as follow:
- Albers-Schönberg Osteopetrosis
This entity is classified as genetic macular dystrophy in ORDO system [25], while blindness, optic atrophy and visual loss are only the main ophthalmic complications reported by different studies cited by OMIM system [26–29]. This concept is categorized as a type of "hereditary disorder of the musculoskeletal system" by SNOMED-CT and ICD-11 considered it as a subtype of osteopetrosis diagnosis [30]. - Foveal Hypoplasia—Presenile Cataract Syndrome
This concept is classified as IRD by ORDO without additional explanation [31]. UMLS provides a CUI with no explanation, while it is not represented in SNOMED-CT. It is classified as a subtype of "other cataract" related to "Infantile and juvenile cataract" classification. Based on OMIM results, it is an ocular disease which is presented with aniridia. - Hermansky—Pudlak Syndrome with Neutropenia
SNOMED-CT does not consider this concept as IRD and classifies it as a metabolic disorder by ICD- 11 as well [32]. A CUI code is assigned for this concept by UMLS system with no additional explanation. In ORDO and OMIM, oculocutaneous albinism is a known ocular finding in these patients [33]. - Leigh Syndrome
This disease is manifested by involvement of the central nervous system (CNS) resulting in ophthalmoplegia as a common ocular finding. OMIM considers it as a disorder of the CNS with no relation to any specific ocular disease [34]. Vision loss and eye movement abnormality are the common ocular findings, as shown in UMLS. Both SNOMED-CT and ICD- 11 considered this diagnosis as a hereditary disorder of the CNS, as well [35]. - Metachromatic Leukodystrophy
ICD- 11 system considered it as a subtype of metabolic disease [36], but UMLS and SNOMED-CT consider it as a hereditary disorder of the nervous system with no ocular manifestation. OMIM system reports no ocular finding [37]. - Rubinstein—Taybi Syndrome
It is considered as congenital glaucoma by OMIM system [38]. Glaucoma, refractive error and nasolacrimal duct obstruction are common ocular findings reported by ORDO system [39]. SNOMED-CT classifies this concept as hereditary cancer predisposing syndrome. No ocular findings were reported by UMLS system. ICD- 11 also considers it as a congenital anomaly [40]. - Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations
SNOMED-CT does not specify any code for this diagnosis, while UMLS has a CUI for it with no definition. Hereditary vascular retinopathy, hereditary endotheliopathy with retinopathy as well as progressive visual impairment are all represented as ocular manifestations in ORDO [41]. - Revesz syndrome
This concept is classified as IRD by ORDO with ocular manifestation of bilateral exudative retinopathy [42]. The same definition exists in UMLS. This concept is also covered by OMIM, without any relationship to retinal dystrophies [43]. This concept is classified as a subtype of hereditary disorder of the visual system by SNOMED-CT. - Aceruloplasminemia
This clinical diagnosis is classified as IRD by UMLS, while it is considered a metabolic disease by SNOMED-CT. - Cockayne Syndrome
Photosensitivity is only the visual finding which is included in ORDO [44]. Additionally, the common ocular manifestations represented in UMLS are photosensitivity, vision impairment, and retinal pigmentation. Congenital cataract is a single ocular finding reported by OMIM, while ICD- 11 emphasizes on congenital malformation in the affected individuals [45]. SNOMED-CT considers it a subtype of hereditary disorder of the nervous system. - Xeroderma Pigmentosum—Cockayn Syndrome Complex
There is no concept code for this diagnosis in UMLS or SNOMED-CT. ORDO classifies it as IRD [46], while ICD- 11 only emphasizes on congenital malformation [47]. There is no finding suggestive of retinal dystrophy presented by OMIM.
Although the proposed classification is the first dedicated hierarchy for subtypes of IRD diagnoses, a suitable linkage to standard terminologies is highly recommended which would be of importance for standardization, maintenance, and reusability of this classification.
The primary purpose of the present study is to present a classification for IRDs and we intend to continue our study focusing on the comparison of our classification system with concepts identified in literature by Natural Language Processing (NLP) algorithms and implementing of this classification in the form of an interface terminology and evaluating user perspectives in terms of usability and clinical applications. Additionally, generation of a mapping between IRD concepts and the target terminologies was a side benefit of our study. Considering the fact that such IRD concepts are inherited via genetic mutations, coding IRD concepts with regards to their genetic mutations is highly desirable.
Although there is no definite cure for IRDs at present, accurate diagnosis and identification of the causative gene mutations can facilitate the creation of animal models for providing gene therapy for IRDs. Therefore, any classification system like ontologies or reference terminologies would become essential tools for personalized medicine specific to IRD diseases and facilitate the description and specification of complex IRD concepts based on the genotype-phenotype distinction.
Considering functional and anatomical attributes, within seven categories, in our IRD classification is the most prominent factor in the proposed classification, which would certainly be helpful in designing future studies focusing on each IRD subtype.
Considering the fact that the World Health Organization (WHO) has already developed the ICD-11 Ophthalmology Specialty Linearization, the proposed classification can be considered a hierarchical prototype for the particular type of ophthalmic diseases.
In conclusion, the specialized classification system that we created, including terms and concepts, is dedicated to various types of IRD diagnosis and has the potential to be applied in the clinics and electronic information systems. More importantly, it may be considered as a preliminary step toward development of a standard ontology for inherited retinal diseases. In addition, the study indicates that many of available terminology systems has little coverage of IRD concepts and only UMLS covers more than 90 percent of concepts. Therefore, our classification system can also be applied to develop and update further versions of standard classification systems.
Methods
In our proposed classification system, each IRD disease is mainly grouped based on the main origin of its pathological problem considering both anatomical and functional concepts. Three steps were taken in our study to develop IRD classification and evaluate the content coverage of terminological systems regarding the IRD concepts.
Step I: Development of a classification for IRD concepts
Initially, a working group of two academic, board-certified retina specialists, one academic molecular geneticist, and five medical informatics specialists was organized. Then, a comprehensive literature review on IRDs was conducted including the textbooks [48–50], and original and review articles [5, 51–80] in order to develop a primary classification based on the anatomical, functional, and pathological concepts related to IRDs. Afterwards, a comprehensive search was conducted up to December 2022 on five terminological systems, including UMLS, ICD-11, SNOMED-CT, ORDO and OMIM to look for any existing terminology for different genetic and phenotypic IRDs to be added accordingly to our primary classification. Then, a questionnaire was developed based on the identified diagnoses, where it was discussed with an expert panel of nine academic board-certified retina specialists regarding the scientific and conceptual accuracy of each IRD concept. Ten expert panel discussion sessions with an interval of one month were held in order to collect all comments and feedback. In each session, 40 IRD concepts were reviewed. After this phase, some irrelevant or duplicated IRD concepts were dropped from the classification list and some concepts were classified in the updated categories based on their functional and anatomical characteristics. All participants were asked to provide "yes", "no" or “maybe” response to “validated”, “not validated”, and “suspected” concepts, respectively. IRD concepts that were labelled as "maybe" were discussed in the subsequent sessions of the expert panel to yield confirmation. This process continued until reaching a final decision. The concepts labeled as “yes” with an agreement of 70% or more were considered as IRD concept, otherwise they were defined as “not validated” IRD concept. To obtain a comprehensive consensus, the summary of the results of the previous sessions was presented in the succeeding meetings. Eventually, after applying the proposed changes to the classification it was finalized based on the consensus of the panel group members based on the workflow represented in Fig 1. Finally, an organized hierarchy of IRD concepts was developed in an ontology editor platform called Protégé (Fig 2). This proposed classification was structured based on the phenotype characteristics and the genetic concepts were included to the related IRD diagnosis.
IRD, inherited retinal dystrophy. 1 Presented on Supplementary data, Table 1. 2 Presented on Supplementary data, Table 2. 3 Developed by Protégé software and it could be accessible on BioPortal website through the URL address of http://bioportal.bioontology.org/ontologies/IRD3.
Step II: Extraction of annotation for each IRD concept
In this phase, all annotations for each IRD concept including code, fully specified name, synonyms (alternative descriptions) in other terminological systems were extracted by two experts: a vision scientist and a medical informatics specialist. This information was documented in a separate datasheet for further comparison. We also assigned a unique internal code for each IRD concept in order to create a mapping network for future data integration.
Step III: Comparison among terminological systems for content coverage analysis
Content coverage analysis was conducted from two aspects; terms and concepts [81]. As previously stated, term- and concept- coverage are considered as the extent of term and concept representation of our proposed classification based on the five mentioned terminological systems.
Initially, each IRD concept in our classification was checked against terminological systems in order to find the relevant or equivalent terms and/or concepts. We classified our results as "no match", "partial match" or "complete match". An IRD concept was considered as term- and concept- matched if the term was completely representable throughout the above-mentioned terminological systems. Further evaluation regarding concept matching was performed for no-term-matched IRD contents. "Complete concept match" was defined in cases where alternative terms (or synonymous) existed. In SNOMED-CT, we considered post-coordination if no synonym was found. In fact, if it was possible to develop a concept with post-coordination, we considered that concept as “partial match”. IRD contents with no possibility of post-coordination were considered as “complete no match”. The percentage for each of the above- mentioned conditions was reported by the terminological systems. Our content coverage approach is illustrated in Fig 3. An example of the content coverage analysis of IRD concepts based on the SNOMED- CT system is shown in Fig 4.
Declarations
Ethics approval and consent to participate
The study details were presented to the Ethics Committee of the Ophthalmic Research Center affiliated to Shahid Beheshti University of Medical Sciences and approved via the registration number of IR.SBMU.ORC.REC.1396.15. This article does not contain any studies with human participants or animals performed by any of the authors, therefore the informed consent was waived based on the local Research Ethics Committee decision.
Supporting information
S1 File. All terminological systems and causative gene.
https://doi.org/10.1371/journal.pone.0281858.s001
(XLSX)
S1 Table. A preliminary classification of inherited retinal dystrophy (IRD) concepts.
https://doi.org/10.1371/journal.pone.0281858.s002
(DOCX)
S2 Table. Not validated concepts as inherited retinal dystrophy (IRD).
https://doi.org/10.1371/journal.pone.0281858.s003
(DOCX)
S3 Table. Classification of IRD concepts in our proposed ontology and applied standard terminological system.
https://doi.org/10.1371/journal.pone.0281858.s004
(DOCX)
S4 Table. A list of IRD concepts coded by all systems and those coded by none of systems.
https://doi.org/10.1371/journal.pone.0281858.s005
(DOCX)
Acknowledgments
The authors desire to express their deep gratitude to the research subcommittee of the Iranian National Registry for Inherited Retinal Diseases (IRDReg®).
References
- 1. Bertelsen M, Jensen H, Bregnhøj JF, Rosenberg T. Prevalence of generalized retinal dystrophy in Denmark. Ophthalmic Epidemiol. 21(4):217–23 (2014). pmid:24963760
- 2. Oh KT, et al. Electroretinographic findings in patients with Stargardt disease and fundus flavimaculatus. Retina. 24(6):920–8 (2004). pmid:15579991
- 3. Azoulay L, et al. Threshold levels of visual field and acuity loss related to significant decreases in the quality of life and emotional states of patients with retinitis pigmentosa. Ophthalmic Res. 54(2):78–84 (2015). pmid:26228470
- 4.
O’Neal TB, Luther EE. Retinitis Pigmentosa. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing (2019).
- 5. Hohman TC. Hereditary Retinal Dystrophy. Handb Exp Pharmacol. 2017;242:337–367 (2017). pmid:28035529
- 6. Cimino JJ, Zhu X. The practical impact of ontologies on biomedical informatics. Yearb Med Inform. 124–35 (2006). pmid:17051306
- 7. Wilkinson MD, et al. Addendum: The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 6(1):6 (2019). pmid:30890711
- 8. Sergouniotis PI, et al. An ontological foundation for ocular phenotypes and rare eye diseases. Orphanet J Rare Dis. 14(1):8 (2019). pmid:30626441
- 9. Taheri Moghadam S, et al. Patient safety classifications for health information technology (HIT) and medical devices: A review on available systems. Stud Health Technol Inform. 293: 153–60 (2022). pmid:35592975
- 10. Khorrami F, Ahmadi M, Sheikhtaheri A. Evaluation of SNOMED CT Content Coverage: A Systematic Literature Review. Stud Health Technol Inform. 248:212–219 (2018). pmid:29726439
- 11. Brønnum D, Højen AR, Gøeg KR, Elberg PB2. Terminology-Based Recording of Clinical Data for Multiple Purposes Within Oncology. Stud Health Technol Inform. 228:267–71 (2016).
- 12. Hwang JC, et al. Representation of ophthalmology concepts by electronic systems: intercoder agreement among physicians using controlled terminologies. Ophthalmology. 113(4):511–9 (2006). pmid:16488013
- 13. Chiang MF, Casper DS, Cimino JJ, Starren J. Representation of ophthalmology concepts by electronic systems: adequacy of controlled medical terminologies. Ophthalmology.112(2):175–83 (2005). pmid:15691548
- 14. Cusack CM, et al. The future state of clinical data capture and documentation:a report from AMIA’s 2011 PolicyMeeting. J Am Med Inform Assoc. 20(1):134–40 (2013). Epub 2012 Sep 8. pmid:22962195
- 15. Randorff Højen A, Sundvall E, Rosenbeck Gøeg K. Visualizing sets of SNOMED CT concepts to support consistent terminology implementation and reuse of clinical data. Stud Health Technol Inform. 192:1160 (2013). pmid:23920934
- 16.
Cardillo E. Mapping between international medical terminologies. Annex 4 to SHN Work Package 3, Deliverable D3.3. Page 5. [Retrieved from www.semantichealthnet.eu at 2019, May 5] (2015).
- 17. Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res. 32(Database issue): D267–D270 (2004). pmid:14681409
- 18. Tanno LK, Chalmers RJ, Calderon MA, Aymé S, Demoly P; on behalf the Joint Allergy Academies. Reaching multidisciplinary consensus on classification of anaphylaxis for the eleventh revision of the World Health Organization’s (WHO) International Classification of Diseases (ICD-11). Orphanet J Rare Dis.12(1):53 (2017).
- 19. McKusick VA. Mendelian Inheritance in Man and its online version, OMIM. Am J Hum Genet. 80(4):588–604 (2007). pmid:17357067
- 20. Sampalli T, Shepherd M, Duffy J, Fox R. An evaluation of SNOMED CT in the domain of complex chronic conditions. Int J Integr Care. 10:e038 (2010). pmid:20422022
- 21. Taheri Moghadam S, Hooman N, Sheikhtaheri A. Patient safety classifications, taxonomies and ontologies: A systematic review on development and evaluation methodologies. J Biomed Inform. 133: 10415 (2022). pmid:35878822
- 22. Amith M, He Z, Bian J, Lossio-Ventura JA, Tao C. Assessing the practice of biomedical ontology evaluation: Gaps and opportunities. J Biomed Inform. 80:1–13 (2018). pmid:29462669
- 23. Cornet R, de Keizer NF, Abu-Hanna A. A framework for characterizing terminological systems. Methods Inf Med. 45(3):253–66 (2006). pmid:16685333
- 24. Mao H, et al. CrowdMapping: A Crowdsourcing-Based Terminology Mapping Method for Medical Data Standardization. Stud Health Technol Inform. 245:511–515 (2017). pmid:29295147
- 25.
Albers-Schönberg Osteopetrosis. Orphanet. https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=255&Disease_Disease_Search_diseaseGroup=Albers-SchonbergOsteopetrosis&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Albers-Schonberg-osteopetrosis&title=Albers-Sch%F6nberg%20osteopetrosis&search=Disease_Search_Simple. Accessed August 10, 2018.
- 26.
Albers-Schönberg Osteopetrosis. Online Mendelian Inheritance in Man (OMIM). https://omim.org/entry/166600. Accessed August 10, 2018.
- 27. Bénichou OD, Laredo JD, de Vernejoul MC. Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients. Bone. 2000;26(1):87–93.
- 28. Walpole IR, Nicoll A, Goldblatt J. Autosomal dominant osteopetrosis type II with "malignant" presentation: further support for heterogeneity? Clin Genet. 1990;38(4):257–63. pmid:2268972
- 29. Waguespack SG, Hui SL, Dimeglio LA, Econs MJ. Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation. J Clin Endocrinol Metab. 2007;92(3):771–8. pmid:17164308
- 30.
Albers-Schönberg Osteopetrosis. International Classification of Diseases (ICD). https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1498426606. Accessed August 10, 2018.
- 31.
Foveal Hypoplasia—Presenile Cataract Syndrome. Orphanet. https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=512&Disease_Disease_Search_diseaseGroup=Foveal-Hypoplasia—Presenile-Cataract-Syndrome&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Foveal-hypoplasia-presenile-cataract-syndrome&title=Foveal%20hypoplasia-presenile%20cataract%20syndrome&search=Disease_Search_Simple. Accessed August 10, 2018.
- 32.
Hermansky—Pudlak Syndrome with Neutropenia. International Classification of Diseases (ICD). https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1189424097. Accessed August 10, 2018.
- 33.
Hermansky—Pudlak Syndrome with Neutropenia. Orphanet. https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=18309&Disease_Disease_Search_diseaseGroup=Hermansky—Pudlak-Syndrome-with-Neutropenia&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Hermansky-Pudlak-syndrome-with-neutropenia&title=Hermansky-Pudlak%20syndrome%20with%20neutropenia&search=Disease_Search_Simple. Accessed August 10, 2018.
- 34.
Leigh Syndrome. Online Mendelian Inheritance in Man (OMIM). https://www.omim.org/entry/256000?search=Leigh%20Syndrome&highlight=%28syndrome%7Csyndromic%29. Accessed August 10, 2018.
- 35.
Leigh Syndrome. International Classification of Diseases (ICD). https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/672871576. Accessed August 10, 2018.
- 36.
Metachromatic Leukodystrophy. International Classification of Diseases (ICD). https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/172326564. Accessed August 10, 2018.
- 37.
Metachromatic Leukodystrophy. Online Mendelian Inheritance in Man (OMIM). https://www.omim.org/entry/250100?search=Metachromatic%20Leukodystrophy&highlight=leukodystrophy%20metachromatic. Accessed August 10, 2018.
- 38.
Rubinstein—Taybi Syndrome. Online Mendelian Inheritance in Man (OMIM). https://www.omim.org/entry/180849?search=Rubinstein%20%20Taybi%20Syndrome&highlight=%28syndrome%7Csyndromic%29. Accessed August 10, 2018.
- 39.
Rubinstein—Taybi Syndrome. Orphanet. https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=151&Disease_Disease_Search_diseaseGroup=Rubinstein—Taybi-Syndrome&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Rubinstein-Taybi-syndrome&title=Rubinstein-Taybi%20syndrome&search=Disease_Search_Simple. Accessed August 10, 2018.
- 40.
Rubinstein—Taybi Syndrome. International Classification of Diseases (ICD). https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1106405864/mms/other. Accessed August 10, 2018.
- 41.
Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations. Orphanet. https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=19537&Disease_Disease_Search_diseaseGroup=Retinal-Vasculopathy-with-Cerebral-Leukoencephalopathy-and-Systemic-Manifestations&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Retinal-vasculopathy-with-cerebral-leukoencephalopathy-and-systemic-manifestations&title=Retinal%20vasculopathy%20with%20cerebral%20leukoencephalopathy%20and%20systemic%20manifestations&search=Disease_Search_Simple. Accessed August 10, 2018.
- 42.
Revesz syndrome. Orphanet. https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=2771&Disease_Disease_Search_diseaseGroup=Revesz-syndrome&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Revesz-syndrome&title=Revesz%20syndrome&search=Disease_Search_Simple. Accessed August 10, 2018.
- 43.
Revesz syndrome. Online Mendelian Inheritance in Man (OMIM). https://www.omim.org/entry/268130?search=Revesz%20syndrome&highlight=%28syndrome%7Csyndromic%29. Accessed August 10, 2018.
- 44.
Cockayne Syndrome. Orphanet. https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=638&Disease_Disease_Search_diseaseGroup=Cockayne-Syndrome&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Cockayne-syndrome&title=Cockayne%20syndrome&search=Disease_Search_Simple. Accessed August 10, 2018.
- 45.
Cockayne Syndrome. International Classification of Diseases (ICD). https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1520135105. Accessed August 10, 2018.
- 46.
Xeroderma Pigmentosum—Cockayn Syndrome Complex. Orphanet. https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=18903&Disease_Disease_Search_diseaseGroup=Xeroderma-Pigmentosum—Cockayne-Syndrome-Complex&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Xeroderma-pigmentosum-Cockayne-syndrome-complex&title=Xeroderma%20pigmentosum-Cockayne%20syndrome%20complex&search=Disease_Search_Simple. Accessed August 10, 2018.
- 47.
Xeroderma Pigmentosum—Cockayn Syndrome Complex. https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1520135105. Accessed August 10, 2018.
- 48.
Cantor LB, Rapuano CJ, Cioffi GA. American Academy of Ophthalmology. Basic and Clinical Science Course (BCSC): Section 12: Retina and Vitreous. 2015–2016. Hermann D. Schubert. Chapters 11 & 12. Pages 209–238.
- 49.
Kanski JJ, Bowling B. Clinical Ophthalmology: A Systemic Approach. 7th edition. 2011. Chapter 15. Pages 647–683.
- 50.
Ryan SJ. Sadda SVR. Retina. 4th edition. Volume 2. Chapter 40. Section 1. 2013. Pages 761–822.
- 51. Kumaran N, Moore AT, Weleber RG, Michaelides M. Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions. Br J Ophthalmol. 2017;101(9):1147–1154. pmid:28689169
- 52. Mathur P, Yang J. Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities. Biochim Biophys Acta. 2015;1852(3):406–20. pmid:25481835
- 53. Tsang SH, Sharma T. Progressive Cone Dystrophy and Cone-Rod Dystrophy (XL, AD, and AR). Adv Exp Med Biol. 2018;1085:53–60. pmid:30578485
- 54. Tsang SH, Sharma T. Blue Cone Monochromatism. Adv Exp Med Biol. 2018;1085:65–66. pmid:30578487
- 55. Tanna P, Strauss RW, Fujinami K, Michaelides M. Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options. Br J Ophthalmol. 2017;101(1):25–30. pmid:27491360
- 56. Andrade LJ, Andrade R, França CS, Bittencourt AV. Pigmentary retinopathy due to Bardet-Biedl syndrome: case report and literature review. Arq Bras Oftalmol. 2009;72(5):694–6. pmid:20027412
- 57. Dimopoulos IS, Radziwon A, St Laurent CD, MacDonald IM. Choroideremia. Curr Opin Ophthalmol. 2017;28(5):410–415. pmid:28520608
- 58.
Vargas M, Mitchell A, Yang P, Weleber R. Bietti Crystalline Dystrophy. Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2019.
- 59. Haji Abdollahi S, Hirose T. Stargardt-Fundus flavimaculatus: recent advancements and treatment. Semin Ophthalmol. 2013;28(5–6):372–6. pmid:24138045
- 60. Glacet-Bernard A, Soubrane G, Coscas G. [Macular vitelliform degeneration in adults. Retrospective study of a series of 85 patients]. J Fr Ophtalmol. 1990;13(8–9):407–20. [Article in French]
- 61.
Tripathy K, Salini B. Best Disease. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019-.
- 62. Guziewicz KE, Sinha D, Gómez NM, Zorych K, Dutrow EV, Dhingra A, Mullins RF, Stone EM, Gamm DM, Boesze-Battaglia K, Aguirre GD. Bestrophinopathy: An RPE-photoreceptor interface disease. Prog Retin Eye Res. 2017;58:70–88. pmid:28111324
- 63. Tsang SH, Sharma T. Doyne Honeycomb Retinal Dystrophy (Malattia Leventinese, Autosomal Dominant Drusen). Adv Exp Med Biol. 2018;1085:97–102. pmid:30578491
- 64. Tsang SH, Sharma T. Sorsby Pseudoinflammatory Fundus Dystrophy. Adv Exp Med Biol. 2018;1085:105–108. pmid:30578493
- 65. Tsang SH, Sharma T. Occult Macular Dystrophy. Adv Exp Med Biol. 2018;1085:103–104. pmid:30578492
- 66. Chiang JP, Trzupek K. The current status of molecular diagnosis of inherited retinal dystrophies. Curr Opin Ophthalmol. 2015;26(5):346–51. pmid:26214332
- 67. van Lith-Verhoeven JJ, Cremers FP, van den Helm B, Hoyng CB, Deutman AF. Genetic heterogeneity of butterfly-shaped pigment dystrophy of the fovea. Mol Vis. 2003;9:138–43. pmid:12724643
- 68. Boon CJ, Klevering BJ, Cremers FP, Zonneveld-Vrieling MN, Theelen T, Den Hollander AI, et al. Central areolar choroidal dystrophy. Ophthalmology. 2009;116(4):771–82, 782.e1. pmid:19243827
- 69. Tsang SH, Sharma T. Enhanced S-Cone Syndrome (Goldmann-Favre Syndrome). Adv Exp Med Biol. 2018;1085:153–156. pmid:30578501
- 70. Verbakel SK, van Huet RAC, Boon CJF, den Hollander AI, Collin RWJ, Klaver CCW5, Hoyng CB1, Roepman R6, Klevering BJ7. Non-syndromic retinitis pigmentosa. Prog Retin Eye Res. 2018;66:157–186. pmid:29597005
- 71. Hamel CP. Cone rod dystrophies. Orphanet J Rare Dis. 2007;2:7. pmid:17270046
- 72. Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1:40. pmid:17032466
- 73. Priya S, Nampoothiri S, Sen P, Sripriya S. Bardet-Biedl syndrome: Genetics, molecular pathophysiology, and disease management. Indian J Ophthalmol. 2016;64(9):620–627. pmid:27853007
- 74.
Paisey RB, Steeds R, Barrett T, Williams D, Geberhiwot T, Gunay-Aygun M. Alström Syndrome. Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2019.
- 75. Klouwer FC, Berendse K, Ferdinandusse S, Wanders RJ, Engelen M, Poll-The BT. Zellweger spectrum disorders: clinical overview and management approach. Orphanet J Rare Dis. 2015;10:151. pmid:26627182
- 76. Braverman NE, Raymond GV, Rizzo WB, Moser AB, Wilkinson ME, Stone EM, Steinberg SJ, Wangler MF, Rush ET, Hacia JG, Bose M. Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines. Mol Genet Metab. 2016;117(3):313–21. pmid:26750748
- 77. Brunetti-Pierri N, Scaglia F. GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. Mol Genet Metab. 2008;94(4):391–6. pmid:18524657
- 78. Kaur A, Dhir SK, Goyal G, Mittal N, Goyal RK. Senior Loken Syndrome. J Clin Diagn Res. 2016;10(11):SD03–SD04. pmid:28050464
- 79.
MacDonald IM, Hoang S, Tuupanen S. X-Linked Congenital Stationary Night Blindness. Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2019.
- 80. Takkar B, Soni D, Pillay G. Oguchi Disease: The Chameleon in the Retina. Ophthalmol Retina. 2019;3(2):139. pmid:31014762
- 81. Arts DG, Cornet R, de Jonge E, de Keizer NF. Methods for evaluation of medical terminological systems—a literature review and a case study. Methods Inf Med. 2005;44(5):616–25. pmid:16400369